ABO blood group predisposes to COVID-19 severity and cardiovascular diseases
- PMID: 32343152
- PMCID: PMC7717262
- DOI: 10.1177/2047487320922370
ABO blood group predisposes to COVID-19 severity and cardiovascular diseases
Figures

Comment in
-
C3 and ACE1 polymorphisms are more important confounders in the spread and outcome of COVID-19 in comparison with ABO polymorphism.Eur J Prev Cardiol. 2020 Aug;27(12):1331-1332. doi: 10.1177/2047487320931305. Epub 2020 May 27. Eur J Prev Cardiol. 2020. PMID: 32460534 Free PMC article. No abstract available.
-
The morbidity and mortality of COVID-19 are associated with ABO and Rh blood groups.Eur J Prev Cardiol. 2021 Sep 20;28(11):e26-e28. doi: 10.1177/2047487320939216. Epub 2020 Jul 7. Eur J Prev Cardiol. 2021. PMID: 34551081 Free PMC article. No abstract available.
References
-
- World Health Organization. Coronavirus Disease (COVID-19) Situation Report, Volume 55 Geneva: World Health Organization, 2020.
-
- Ibrahim MM. RAS inhibition in hypertension. J Hum Hypertens 2006; 20: 101–108. - PubMed
-
- Fang Y, Gao F, Liu Z Angiotensin-converting enzyme 2 attenuates inflammatory response and oxidative stress in hyperoxic lung injury by regulating NF-kappaB and Nrf2 pathways. Q J Med 2019; 112: 914–924. - PubMed